Latest Breaking News On - Ciara martin - Page 1 : comparemela.com

Study of ovarian cancer CTCs using Parsortix | Company Announcement

Investegate announcements from Study of ovarian cancer CTCs using Parsortix

United statesToby flauxCiaran walshMilo bonserAndrew newlandCiara martinIan griffithsSimon conwayKaren millerUniversity of viennaInternational journal of cancerResearch useAmerican cancer societyFramework programme grantFramework programmeMedical university

New commercial agreement with large pharma | Company Announcement

Investegate announcements from New commercial agreement with large pharma

United kingdomSimon conwayMilo bonserCiaran walshToby flauxIan griffithsAndrew newlandCiara martinKaren millerResearch useParsortix based androgen receptorParsortix based androgenExecutive officerScientific officerCorporate brokerMarket abuse regulation

Angle PLC Announces New Commercial Agreement with AstraZeneca

Angle PLC Announces New Commercial Agreement with AstraZeneca
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSimon conwayToby flauxMilo bonserCiaran walshKaren millerCiara martinIan griffithsAndrew newlandLondon stock exchangeResearch useFinancial conduct authorityExecutive officerScientific officerCorporate broker

Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide

Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide .

United kingdomUnited statesCity ofAndrew newlandToby flauxCiaran walshKaren millerCiara martinIan griffithsMilo bonserSimon conwayResearch useLondon stock exchangeFinancial conduct authorityEuropean patent officeTrademark office

Data from Newron s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 01:02 am EDT

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual.

Kyongsang buktoSouth koreaSri lankaUnited statesUnited kingdomUnited arab emiratesStefan weberAnne hennecke caroline bergmannValentin handschinPaul saganSchizophrenia international research societyEuropean unionMc servicesSupernus pharmaceuticalsNewron pharmaceuticalsNegative syndrome scale